IRC
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

IRC Trademark

Serial Number: 78204474 • Registration: 2930514

IRC is a trademark filed by SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S) on January 17, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S) (30 trademarks)

51/53 rue du Docteur Blanche
75016 PARIS , FR

Entity Type: 03

IPSEN PHARMA S.A.S. (153 trademarks)

65 QUAI GEORGES GORSE
BOULOGNE-BILLANCOURT 92100 , FR

Entity Type: 11

Trademark Details

Filing Date

January 17, 2003

Registration Date

March 8, 2005

Published for Opposition

May 11, 2004

Cancellation Date

October 14, 2011

Goods & Services

Pharmaceutical preparations for use in the treatment of gastrointestinal diseases, laxatives and purgative agents, pharmaceutical preparations for use in the treatment of cardiovascular diseases, pharmaceutical preparations for the treatment of circulatory disorders, pharmaceutical preparations for use in the treatment of cancer, pharmaceutical preparations for use in the treatment of neurological diseases, pharmaceutical preparations for use in the treatment of urological diseases; pharmaceutical preparations for use in the treatment of hormonal disorders, pharmaceutical preparations comprising peptides for hormonal treatment and tumor treatment, pharmaceutical preparations for use in the treatment of endocrine disorders, pharmaceutical preparations for the treatment of acromegalia and carcinoid tumors, pharmaceutical preparations for use in the treatment blood diseases, pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders, pharmaceutical preparations for use in the treatment of muscle disorders, pharmaceutical preparations for the treatment of age-related disorders, pharmaceutical preparations for the treatment of respiratory disorders, pharmaceutical preparations for the treatment of opthalmological disorders, pharmaceutical preparations against cough; pharmaceutical preparations for the treatment of vertigo; nausea, vomitic and migraine, pharmaceutical preparations for the treatment of disorders and diseases of the reproductive system, pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymetries and defects and conditions of the human skin

Chemicals and chemical compounds used in research and development in the pharmaceutical field; chemicals and chemical compounds for use in the manufacture of pharmaceuticals

Research and development services for pharmaceutical products.

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 14, 2011 C8..
REVIEW OF CORRESPONDENCE COMPLETE
Dec 16, 2009 CORV
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 16, 2009 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 1, 2009 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 5, 2005 TCCA
PAPER RECEIVED
Mar 24, 2005 MAIL
REGISTERED-PRINCIPAL REGISTER
Mar 8, 2005 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 12, 2004 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
May 12, 2004 ETOF
PUBLISHED FOR OPPOSITION
May 11, 2004 PUBO
NOTICE OF PUBLICATION
Apr 21, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2004 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2004 CRFA
PAPER RECEIVED
Feb 9, 2004 MAIL
LETTER OF SUSPENSION E-MAILED
Jan 14, 2004 GNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2003 CRFA
PAPER RECEIVED
Dec 16, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2003 CRFA
FAX RECEIVED
Dec 15, 2003 FAXX
NON-FINAL ACTION E-MAILED
Jun 16, 2003 GNRT
ASSIGNED TO EXAMINER
Jun 16, 2003 DOCK